<?xml encoding="utf-8" ?> Belite Bio Inc. BLTE drew a bullish initiation from Canaccord Genuity, which sees significant ...
Cabaletta Bio (CABA) fast making headway with its lead asset CABA-201 for the treatment of patients with autoimmune disorders. This is a CD-19 CAR-T therapy being used for the treatment of patients ...
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming ...
Q32 Bio has surged over 750% in the past year, driven by its lead program, bempikibart, for alopecia areata (AA). Click here ...
Shares of small biotech Instil Bio TIL have surged more than six times in market value in the past week. The upside came after rival Summit Therapeutics SMMT reported encouraging data from a ...
JPMorgan started Nuvation Bio at Overweight with a $13 target, roughly double, citing its fast-selling lung cancer pill. Learn about the case and risks.
Stocks are often cheap for a reason, so when investors come across a company whose shares are trading for under $3.50 apiece and with a market capitalization of $350 million, that naturally raises ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results